Have Any Questions? +1 (410) 379-1500 info@vicihealthsciences.com
  • Home
  • About Us
  • Careers
  • Contact
  • News
Vici Health Sciences
  • CDMO Services
    • Formulation Development Services
      • Oral formulations
      • Topical formulations
      • Injectable and ophthalmic formulations
    • cGMP Manufacturing
      • Phase 1 and Phase 2 Clinical Manufacturing
      • Phase 3 Clinical and Commercial Manufacturing
    • Analytical Testing Services
    • API and intermediates synthesis
  • R&D Services
  • Blog
Select Page
Vici Health Sciences is announcing its successful completion of initial clinical studies for its 505(b)(2) product pipeline

Vici Health Sciences is announcing its successful completion of initial clinical studies for its 505(b)(2) product pipeline

by Alex Brown | Jan 3, 2020 | News

ELKRIDGE, MD. (PRWEB) DECEMBER 27, 2019 Vici Health Sciences is announcing its successful completion of initial clinical studies for its 505(b)(2) product pipeline that offers patients and healthcare providers options in the treatment of chronic diseases that...
Next Entries »

CONTACT

+1 (410) 379-1500

info@vicihealthsciences.com

6655 Amberton Drive, Unit O, Elkridge,
MD 21075

OUR SERVICES

  • Oral Formulation Development
  • Parenteral Formulation Development
  • Analytical Testing Services
  • GMP Clinical Manufacturing
  • Regulatory Filing Services
  • Technical R&D Consultation
  • CMO Selection and Management

QUICK LINKS

  • Home
  • About Us
  • Careers
  • Contact
  • News
  • Blog
2023 © Copyrights - Vici Health Sciences | All Rights Reserved